Patheon completes production expansion
Contracting giant Patheon hopes that new intermediate scale, QbD compatible API manufacturing capabilities will broaden its offering to the drug industry and enable it to cement its market position.
Contracting giant Patheon hopes that new intermediate scale, QbD compatible API manufacturing capabilities will broaden its offering to the drug industry and enable it to cement its market position.
API maker Cody Laboratories is targeting the lucrative analgesic and pain management markets with a new process that improves the efficiency of hydromorphone and hydrocodone manufacture.
The implementation of California’s ePedigree system has been knocked back yet again, with 1 January 2015 now the proposed date.
US-based contract research organisation Medelis has founded a European division, Medelis Europe, to bring its expertise in oncology clinical trials design and management to customers wanting to launch drugs in Europe.
A bill has been introduced to the US Senate that would require the country-of-origin of APIs and excipients to be labeled on finished dosage forms.
After months of deliberations, a court in Iowa has opted to fine contract manufacturing company Cambrex $6,000 for safety violations after an explosion at its facility in Charles City.
The 2008 Nobel Prize for Chemistry has been awarded equally to three chemists "for the discovery and development of the green fluorescent protein (GFP),” one of the most important tools in bioscience.
Dutch sample and assay technology expert Qiagen has continued its march into the detection system market with the acquisition of Biotage’s Biosystems business.